Noura N. Alraouji

Riyadh, 11211, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Eugenoplatin (a phyto-chemo drug conjugate) targets cancer stem cells through inhibition of the β-catenin signaling in triple-negative breast cancer cells.

Eugenoplatin (a phyto-chemo drug conjugate) targets cancer stem cells through inhibition of the β-catenin signaling in triple-negative breast cancer cells.

Journal: Journal of translational medicine

Published: December 04, 2025

Safety and preliminary efficacy of adding tocilizumab to cisplatin/docetaxel for the treatment of locally advanced triple-negative breast cancer patients: prospective phase 1/2 clinical trial.

Safety and preliminary efficacy of adding tocilizumab to cisplatin/docetaxel for the treatment of locally advanced triple-negative breast cancer patients: prospective phase 1/2 clinical trial.

Journal: Scientific reports

Published: October 30, 2025

Obesity is a major modifiable factor associated with ER-negative breast cancer: epidemiological and mechanistic evidence from a high-risk cohort.

Obesity is a major modifiable factor associated with ER-negative breast cancer: epidemiological and mechanistic evidence from a high-risk cohort.

Journal: Breast cancer research : BCR

Published: September 15, 2025

Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells.

Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells.

Journal: Cell death discovery

Published: May 28, 2024

Ionizing radiation normalizes the features of active breast cancer stromal fibroblasts and suppresses their paracrine pro-carcinogenic effects.

Ionizing radiation normalizes the features of active breast cancer stromal fibroblasts and suppresses their paracrine pro-carcinogenic effects.

Journal: Translational oncology

Published: July 04, 2023

Activated breast stromal fibroblasts exhibit myoepithelial and mammary stem cells features.

Activated breast stromal fibroblasts exhibit myoepithelial and mammary stem cells features.

Journal: Translational oncology

Published: April 05, 2023

The curcumin analogue PAC has potent anti-anaplastic thyroid cancer effects.

The curcumin analogue PAC has potent anti-anaplastic thyroid cancer effects.

Journal: Scientific reports

Published: October 13, 2022

High AUF1 level in stromal fibroblasts promotes carcinogenesis and chemoresistance and predicts unfavorable prognosis among locally advanced breast cancer patients.

High AUF1 level in stromal fibroblasts promotes carcinogenesis and chemoresistance and predicts unfavorable prognosis among locally advanced breast cancer patients.

Journal: Breast cancer research : BCR

Published: February 09, 2022

Osteoprotegerin (OPG) mediates the anti-carcinogenic effects of normal breast fibroblasts and targets cancer stem cells through inhibition of the β-catenin pathway.

Osteoprotegerin (OPG) mediates the anti-carcinogenic effects of normal breast fibroblasts and targets cancer stem cells through inhibition of the β-catenin pathway.

Journal: Cancer letters

Published: April 08, 2021

Tocilizumab inhibits IL-8 and the proangiogenic potential of triple negative breast cancer cells.

Tocilizumab inhibits IL-8 and the proangiogenic potential of triple negative breast cancer cells.

Journal: Molecular carcinogenesis

Published: September 29, 2020

Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.

Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.

Journal: Molecular carcinogenesis

Published: February 01, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026